Oriola Oyj

Oriola is a Nordic pharmaceutical company that operates in the distribution and wholesale of pharmaceuticals and health products across Finland and Sweden. The company focuses on providing logistics services, dose dispensing, and advisory services to healthcare providers and pharmacies. Oriola has strengthened its market position through strategic acquisitions and investments in advanced distribution centers. The company is committed to sustainability, having set ambitious climate targets validated by the Science Based Targets initiative.

— Oriola Oyj
%
Distribution60% Includes pharmaceutical logistics and dose dispensing services.
Wholesale30% Covers OTC products, special licensed medicines, and parallel import.
Advisory Services10% Offers consulting and data solutions for pharmaceutical companies.

Oriola serves a diverse range of customers including pharmacies, hospitals, veterinarians, and other healthcare...

  • Pharmaciesprimary

    Purchase logistics and wholesale services for efficient supply.

  • Hospitalsprimary

    Rely on Oriola for dose dispensing and pharmaceutical logistics.

  • Veterinarianssecondary

    Source special licensed medicines and OTC products.

  • Healthcare Providersemerging

    Use advisory services for regulatory compliance.

Oriola operates primarily in Finland and Sweden, with a strong presence in the Nordic pharmaceutical distribution...

  • Operates in Finland and Sweden with significant market shares.
  • Distribution centers strategically located for efficient operations.
  • New distribution center in Järvenpää to increase capacity by 30%.
  • Strong presence in Nordic pharmaceutical distribution market.
  • Investments in sustainability and energy efficiency in Finland.

Oriola's strategic priorities include reinforcing customer focus, expanding value-adding services, and improving...

01
Customer Focusshort-term

To enhance service delivery and customer satisfaction.

02
Infrastructure Investmentmedium-term

To support growth and operational efficiency.

03
Sustainabilitylong-term

To align with climate targets and reduce emissions.

Oriola faces several risks including regulatory changes in the pharmaceutical industry, supply chain disruptions, and...

critical

Supply Chain Disruptions

Constraints affecting product availability.

Materiality
high
high

Regulatory Changes

Strict regulations in pharmaceutical distribution.

Materiality
high
high

Geopolitical Uncertainties

Influencing market conditions and operations.

Materiality
medium
high

Cybersecurity Threats

Potential impact on critical operations.

Materiality
medium
Revenue Recognition
medium
Lease Accounting
medium
Estimates and Provisions
high

: 11/08/2026